Natriuretic Peptide Signaling Pathway in Neurodegeneration
📖 Wiki Page
mechanism888 wordssynced 2026-04-02
Natriuretic Peptide Signaling Pathway in Neurodegeneration
The natriuretic peptide (NP) signaling pathway represents a critical link between cardiovascular homeostasis and brain health. Originally characterized for their renal and cardiovascular effects, natriuretic peptides have emerged as important neuroprotective factors with relevance to Alzheimer's disease (AD), Parkinson's disease (PD), and vascular cognitive impairment.
Overview
The natriuretic peptide family includes atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). These peptides signal through three distinct natriuretic peptide receptors (NPRA, NPRB, NPRC), activating intracellular signaling cascades that influence cardiovascular function, fluid balance, and neural cell survival. [@ctype2023]
Peptide Ligands
Atrial Natriuretic Peptide (ANP)
ANP is primarily synthesized in cardiac atrial cells, with lower expression in the brain. It is released in response to atrial stretch and volume loading. In the brain, ANP is produced in the hypothalamus and regulates: [@brain2024]
Sodium balance
Blood pressure
Neuroendocrine function
Stress responses
Brain Natriuretic Peptide (BNP)
BNP was initially identified in brain tissue but is primarily produced in cardiac ventricles. It is widely used as a biomarker for heart failure. In the brain, BNP: [@npr2023]
Modulates neurotransmitter release
Influences neuroendocrine axes
Has neuroprotective properties
...
Natriuretic Peptide Signaling Pathway in Neurodegeneration
The natriuretic peptide (NP) signaling pathway represents a critical link between cardiovascular homeostasis and brain health. Originally characterized for their renal and cardiovascular effects, natriuretic peptides have emerged as important neuroprotective factors with relevance to Alzheimer's disease (AD), Parkinson's disease (PD), and vascular cognitive impairment.
Overview
The natriuretic peptide family includes atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). These peptides signal through three distinct natriuretic peptide receptors (NPRA, NPRB, NPRC), activating intracellular signaling cascades that influence cardiovascular function, fluid balance, and neural cell survival. [@ctype2023]
Peptide Ligands
Atrial Natriuretic Peptide (ANP)
ANP is primarily synthesized in cardiac atrial cells, with lower expression in the brain. It is released in response to atrial stretch and volume loading. In the brain, ANP is produced in the hypothalamus and regulates: [@brain2024]
Sodium balance
Blood pressure
Neuroendocrine function
Stress responses
Brain Natriuretic Peptide (BNP)
BNP was initially identified in brain tissue but is primarily produced in cardiac ventricles. It is widely used as a biomarker for heart failure. In the brain, BNP: [@npr2023]
Modulates neurotransmitter release
Influences neuroendocrine axes
Has neuroprotective properties
C-Type Natriuretic Peptide (CNP)
CNP is widely expressed in the central nervous system and vascular endothelium. It is the most abundant natriuretic peptide in the brain and serves as a: [@natriuretic2024a]
Neurotrophic factor
Neuromodulator
Vasodilator
Receptor Signaling
NPRA (NPR1)
NPRA is the primary guanylyl cyclase receptor for ANP and BNP. It contains an extracellular ligand-binding domain and intracellular guanylyl cyclase domain. [@cnp2023]
Signaling Pathways: [@natriuretic2024b]
cGMP/PKG: NPRA activation increases intracellular cGMP, activating protein kinase G (PKG)
cGMP-gated ion channels: Direct activation of calcium channels
NPRB is the primary receptor for CNP with high affinity for CNP and lower affinity for ANP. It signals through similar cGMP-dependent mechanisms. [@therapeutic2023]
Signaling Pathways: [@natriuretic2024c]
cGMP/PKG: Similar to NPRA but preferentially activated by CNP
MAPK modulation: CNP/NPRB can modulate MAPK signaling through cGMP-independent mechanisms
NPRC (NPR3)
NPRC is a clearance receptor with equal affinity for all natriuretic peptides. It lacks guanylyl cyclase activity and functions primarily to: [@amyloidbeta2023]
Regulate circulating NP levels
Internalize and degrade NPs
Signal through G-protein-coupled mechanisms
Signaling Pathways:
Gi/o coupling: Inhibits adenylate cyclase
MAPK modulation: Can activate or inhibit MAPK pathways
[PubMed: Natriuretic Peptides and Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=natriuretic+neurodegeneration)
Recent Research Updates (2024-2026)
[Elkhial RT et al. 2026: Enhanced Wnt/β-catenin pathway upregulation by sacubitril/valsartan via neprilysin inhibition](https://doi.org/10.1016/j.neuropharm.2026.01.034)